Skip to main content

Table 1 Patients’ characteristics

From: The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy

Characteristics

n

(%)

Age (y)

Median (range)

63

(range, 27–81)

Sex

Male

137

(87%)

 

Female

20

(13%)

Performance

ECOG 0

39

(25%)

 

ECOG 1

111

(71%)

 

ECOG 2

7

(4%)

Histology

Squamous cell carcinoma

86

(55%)

 

Adenocarcinoma

52

(33%)

 

Large cell carcinoma

2

(1%)

 

NSCLC, NOS

17

(11%)

T stage

1

18

(11%)

 

2

61

(39%)

 

3

34

(22%)

 

4

44

(28%)

N stage

0

3

(2%)

 

1

3

(2%)

 

2

75

(48%)

 

3

76

(48%)

Stage

IIIA

49

(31%)

 

IIIB

108

(69%)

  1. Abbreviations: ECOG Eastern Cooperative Oncology Group, NSCLC Non-small-cell lung cancer, NOS Not otherwise specified.